Delivery Order SPE2DB22D3016-SPE2DB25FBDE8
Award Date 7/28/25
Potential Completion Date 8/18/25
Potential Value $29K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $120,192.80 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price contract with an ultimate completion date of August 14, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ocrevus 300 mg/10 mL vials, a specialty pharmaceutical product used in the treatment of multiple sclerosis. This firm fixed-price delivery order, valued at $120,192.80, is set to be completed by August 13, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $69,354.24 firm fixed price contract is for the supply of Ocrevus 300 mg/10 ml vials. Ocrevus is a specialty medication used to treat multiple sclerosis. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a comprehensive range of...
- This is a $48,077.16 firm-fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The contract has an ultimate completion date of July 2, 2025 and is not set aside for any particular business category. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division to provide Ocrevus 300 mg/10 ml vials. The fixed-price contract, valued at $69,354.24, has a completion date of June 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
- The Defense Logistics Agency Troop Support Medical awarded a $113,093.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. The contract calls for Amerisourcebergen to provide 10ML vials of Ocrevus, a multiple sclerosis treatment, to fulfill requirements at locations within its Conshohocken, Pennsylvania facility. The contract period of performance spans from July 21, 2023 through August 11, 2023. No subcontractors or set aside...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 mL vials. The delivery order, valued at $23,118.08, has an ultimate completion date of April 22, 2024. This award is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $45,237.44 to Amerisourcebergen Drug Corporation for the supply of 4562055207 Ocrevus 300 MG/10 ML Vials. Amerisourcebergen will deliver 10ML vials of the multiple sclerosis treatment Ocrevus to a location in Conshohocken, Pennsylvania under a start date of September 5, 2023 concluding on September 26, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. The...
- The Defense Logistics Agency awarded a $33,928 delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. This firm fixed price order is being fulfilled under an existing Prime Vendor Pharmaceutical contract vehicle and will provide 10ML vials of the multiple sclerosis treatment Ocrevus to support DLA missions. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required by July 31, 2023. No subcontractors or set...
- The Defense Logistics Agency Troop Support Medical awarded a $22,618.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. The delivery order is for 10 ML vials of Ocrevus, a multiple sclerosis treatment, to be provided by Amerisourcebergen from its facility in Conshohocken, Pennsylvania. The delivery period is September 26, 2023 through October 18, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency...